株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

世界の体外診断 (IVD) 市場

Global In-Vitro Diagnostics (IVD) Market: Industry Analysis & Outlook 2017-2021

発行 Koncept Analytics 商品コード 223486
出版日 ページ情報 英文 90 Pages
即納可能
価格
本日の銀行送金レート: 1USD=113.21円で換算しております。
Back to Top
世界の体外診断 (IVD) 市場 Global In-Vitro Diagnostics (IVD) Market: Industry Analysis & Outlook 2017-2021
出版日: 2017年10月06日 ページ情報: 英文 90 Pages
概要

当レポートでは、世界における体外診断 (IVD) 市場の発展動向を分析しており、市場の成長促進要因と課題、地域別市場の主な動向、主要企業の市場シェア/プロファイルなどを提供しています。

第1章 概要

  • IVD製品の種類
  • IVD検査
  • 技術別のIVD市場
  • IVDの利用
  • IVDのバリューチェーン分析

第2章 世界のIVD市場

  • 収益
  • 収益予測
  • 地域別市場
  • 製品タイプ別市場
  • 検査ロケーション別市場
  • 技術別市場

第3章 世界のIVD市場:技術別

  • 血糖自己測定 (SMBG) 市場の収益予測
  • 臨床化学市場の収益予測
  • 免疫化学市場
  • 分子診断市場
  • ポイントオブケア (POC) 市場の収益予測
  • 微生物学市場の収益予測
  • 血液学市場の収益予測

第4章 IVDの地域別市場

  • 北米
  • 欧州・中東・アフリカ地域
  • アジア太平洋地域
  • ラテンアメリカ

第5章 市場力学

  • 成長促進要因
  • 主要動向
  • 課題

第6章 競合情勢

  • IVD市場におけるシェア
  • 免疫化学市場におけるシェア
  • 分子診断市場におけるシェア
  • POCT市場におけるシェア
  • 臨床化学市場におけるシェア

第7章 企業プロファイル

このページに掲載されている内容は最新版と異なる場合があります。詳細はお問い合わせください。

目次

Diagnosis is the identification of the nature and cause of a certain phenomenon. It involves two different types of testing method: in vivo and in vitro diagnostics. In-vitro diagnostics (IVDs) tests are defined as tests executed outside a patient's body which put analytical instruments, devices, reagents, calibrators and systems to use for checking of health status or diagnosing diseases. Purpose for doing the IVD test is to prevent, effectively cure and mitigate any kind of risk and for post-treatment intensive care diseases and infections. IVD products are precisely designed and produced for collecting samples derived from the human body and scrutinizing them outside the human body.

The global IVD market is segmented on the basis of product, technology used and test location. On the basis of product, this market can be divided into three sub segments; reagents, analytical instruments and accessory products. By technologies employed, it can be segmented into various sub segments; immunochemistry, SMBG, POCT, molecular diagnostics, clinical chemistry, microbiology, hematology and others. Further, depending upon test location, the market can be divided into three sub segments; labs, POC and self-test.

Growth of the global IVD market is driven by several factors including rapid occurrence of infectious diseases, increasing diabetic patient base, and surge in incidences of chronic ailments. Further, growing geriatric population, rising GDP per capita and increasing healthcare expenditure per capita will act as a catalyst for market growth. Owing to the suitable demographical changes and rising disposable income coupled with improving basic infrastructure, developing regions such as Asia-Pacific and Latin America are expected to experience robust growth. However, the market growth prospects could be hindered by lack of customer adoption, lack of proper facilities and infrastructure and strict government regulations.

The report "Global In-Vitro Diagnostics (IVD) Market: Industry Analysis & Outlook (2017-2021)" analyzes the development of this market, with focus on the North America, EMEA, Asia-Pacific and Latin America markets. The major trends, growth drivers as well as issues faced by the market are discussed in detail in this report. The four major players: Siemens AG., Roche Holdings AG., Abbott Laboratories and Danaher Corp. are being profiled along with their key financials and strategies for growth.

Table of Contents

1. Overview

  • 1.1 In-Vitro Diagnostics (IVD)
  • 1.2 IVD Product by Types
  • 1.3 IVD Tests
  • 1.4 IVD Market by Technology
  • 1.5 IVD Uses
  • 1.6 IVD Value Chain Analysis

2. Global IVD Market

  • 2.1 Global IVD Market by Value
  • 2.2 Global IVD Market Forecast by Value
  • 2.3 Global IVD Market by Region
  • 2.4 Global IVD Market by Indications
  • 2.5 Global IVD Market by Test Location
  • 2.6 Global IVD Market by Product
    • 2.6.1 Global IVD Reagents Market Forecast by Value
    • 2.6.2 Global IVD Instrument Market Forecast by Value
  • 2.7 Global IVD Market by Technology

3. Global IVD Market Analysis by Technology

  • 3.1 Global SMBG Market Forecast by Value
  • 3.2 Global Clinical Chemistry Market Forecast by Value
  • 3.3 Global Immunochemistry Market
    • 3.3.1 Global Immunochemistry Market Forecast by Value
    • 3.3.2 Global Immunochemistry Market by Indications
  • 3.4 Global Molecular Diagnostics Market
    • 3.4.1 Global Molecular Diagnostics Market Forecast by Value
    • 3.4.2 Global Molecular Diagnostics Market by Indications
    • 3.4.3 Global Molecular Diagnostics Market by Regions
  • 3.5 Global Point Of Care (POC) Market Forecast by Value
  • 3.6 Global Microbiology Market
    • 3.6.1 Global Microbiology Market Forecast by Value
    • 3.6.2 Global Microbiology Market by Indication
  • 3.7 Global Hematology Market Forecast by Value

4. Regional IVD Market

  • 4.1 North America
    • 4.1.1 North America IVD Market Forecast by Value
    • 4.1.2 North America Microbiology Market by Indication
    • 4.1.3 The US IVD Market Forecast by Value
  • 4.2 EMEA
    • 4.2.1 EMEA IVD Market Forecast by Value
    • 4.2.2 Europe Microbiology Market by Indications
  • 4.3 Asia-Pacific
    • 4.3.1 Asia-Pacific IVD Market Forecast by Value
    • 4.3.2 China IVD Market Forecast by Value
    • 4.3.3 Japan IVD Market Forecast by Value
  • 4.4 Latin America
    • 4.4.1 Latin America IVD Market Forecast by Value

5. Market Dynamics

  • 5.1 Growth Drivers
    • 5.1.1 Increasing Diabetic Patient Base
    • 5.1.2 Rapid Occurrence of Infectious Diseases
    • 5.1.3 Surge in Incidences of Chronic Ailments
    • 5.1.4 Increasing Global Healthcare Expenditure Per Capita
    • 5.1.5 Rising Global GDP per Capita
    • 5.1.6 Growing Geriatric Population
  • 5.2 Key Trends & Developments
    • 5.2.1 Rise in CFDA IVD Market Approvals
    • 5.2.2 Consolidation of Core Labs
    • 5.2.3 Increasing Penetration of the US LDT Companies in European IVD Market
    • 5.2.4 Mergers & Acquisitions
  • 5.3 Challenges
    • 5.3.1 Lack of Customer Adoption
    • 5.3.2 Urgent Need for Proper Infrastructure
    • 5.3.3 Government Regulation for IVD Tests

6. Competitive Landscape

  • 6.1 Global IVD Market
    • 6.1.1 Revenue and Market Cap. Comparison
    • 6.1.2 Global IVD Market Share by Company
    • 6.1.3 Global Immunochemistry Market Share by Company
    • 6.1.4 Global Molecular Diagnostics Market Share by Company
    • 6.1.5 Global POCT Market Share by Company

7. Company Profiles

  • 7.1 Siemens AG
    • 7.1.1 Business Overview
    • 7.1.2 Financial Overview
    • 7.1.3 Business Strategies
  • 7.2 Roche Holding AG
    • 7.2.1 Business Overview
    • 7.2.2 Financial Overview
    • 7.2.3 Business Strategies
  • 7.3 Abbott Laboratories
    • 7.3.1 Business Overview
    • 7.3.2 Financial Overview
    • 7.3.3 Business Strategies
  • 7.4 Danaher Corporation
    • 7.4.1 Business Overview
    • 7.4.2 Financial Overview
    • 7.4.3 Business Strategies

List of Figures

  • Types of Diagnostics
  • Types of IVD Products
  • Types of IVD Tests
  • IVD Market by Technology
  • IVD Value Chain Analysis
  • Global IVD Market by Value (2012-2016)
  • Global IVD Market Forecast by Value (2017-2021)
  • Global IVD Market by Region (2016)
  • Global IVD Market by Indications (2016)
  • Global IVD Market by Test Location (2016)
  • Global IVD Market by Product (2016)
  • Global IVD Reagents Market Forecast by Value (2016-2021)
  • Global IVD Instrument Market Forecast by Value (2016-2021)
  • Global IVD Market by Technology (2016)
  • Global SMBG Market Forecast by Value (2016-2021)
  • Global Clinical Chemistry Market Forecast by Value (2016-2021)
  • Global Immunochemistry Market Forecast by Value (2016-2021)
  • Global Immunochemistry Market by Indications (2016)
  • Global Molecular Diagnostics Market Forecast by Value (2016-2021)
  • Global Molecular Diagnostics Market by Indications (2016)
  • Global Molecular Diagnostics Market by Regions (2016)
  • Global Point Of Care (POC) Market Forecast by Value (2016-2021)
  • Global Microbiology Market Forecast by Value (2016-2021)
  • Global Microbiology Market by Indication (2016)
  • Global Hematology Market Forecast by Value (2016-2021)
  • North America IVD Market Forecast by Value (2016-2021)
  • North America Microbiology Market by Indication (2016)
  • The US IVD Market Forecast by Value (2016-2021)
  • EMEA IVD Market Forecast by Value (2016-2021)
  • Europe Microbiology Market by Indications (2016)
  • Asia-Pacific IVD Market Forecast by Value (2016-2021)
  • China IVD Market Forecast by Value (2016-2021)
  • Japan IVD Market Forecast by Value (2016-2021)
  • Latin America IVD Market Forecast by Value (2016-2021)
  • Global Type 2 Diabetes Patients Volume (2016-2021)
  • Global New Cancer Patients Volume (2012-2016)
  • Global Healthcare Expenditure Per Capita (2012-2016)
  • Global GDP Per Capita (2012-2016)
  • Global Population above 64 Years (2012-2016)
  • Global IVD Market Share by Company (2016)
  • Global Immunochemistry Market Share by Company (2016)
  • Global Molecular Diagnostics Market Share by Company (2016)
  • Global POCT Market Share by Company (2016)
  • Siemens AG Revenue by Segment (2016)
  • Siemens AG Revenue and Net Income (2012-2016*)
  • Siemens R&D Expenditure (2014-2016*)
  • Roche Holding AG Sales by Segment (2016)
  • Roche Holding AG Sales and Net Income (2012-2016)
  • Roche Holding AG R&D Expenditure (2014-2016)
  • Number of Products in Pipeline by Segments (2016)
  • Abbott Laboratories Sales by Segment (2016)
  • Abbott Laboratories Net Sales and Net Earnings (2012-2016)
  • Abbott Laboratories R&D Expenditure (2014-2016)
  • Danaher Corp. Revenue by Segments (2016)
  • Danaher Corp. Revenue and Net Earnings (2012-2016)
  • Danaher Corp. R&D Expenditure (2014-2016)

List of Charts

  • Growing Cases and Prevalence of STDs in the US (2012-2016)
  • Revenue and Market Cap. Comparison by Companies (2016)
Back to Top